N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide

C38H50N6O8 — CID 135118702

IUPACN-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide
SMILESCC[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc3c(c2)CCCO3)CCCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC1=O
InChIInChI=1S/C38H50N6O8/c1-3-27-34(47)43-32(23(2)45)37(50)42-29(21-24-11-5-4-6-12-24)38(51)44-19-9-15-30(44)36(49)39-18-8-7-14-28(35(48)40-27)41-33(46)26-16-17-31-25(22-26)13-10-20-52-31/h4-6,11-12,16-17,22-23,27-30,32,45H,3,7-10,13-15,18-21H2,1-2H3,(H,39,49)(H,40,48)(H,41,46)(H,42,50)(H,43,47)/t23-,27+,28+,29-,30+,32+/m1/s1
InChIKeyAAOFWHOQKZYYHP-WPJUPHJLSA-N
MW718.85 g/mol
LogP0.89
Rot. Bonds6

About N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide

N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide (PubChem CID 135118702) has the molecular formula C38H50N6O8 and a molecular weight of 718.85 g/mol. Its IUPAC name is N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide.

Molecular Properties

Compound NameN-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide
PubChem CID135118702
Molecular FormulaC38H50N6O8
Molecular Weight718.85 g/mol
Exact Mass718.37
IUPAC NameN-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide
SMILESCC[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc3c(c2)CCCO3)CCCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC1=O
InChIInChI=1S/C38H50N6O8/c1-3-27-34(47)43-32(23(2)45)37(50)42-29(21-24-11-5-4-6-12-24)38(51)44-19-9-15-30(44)36(49)39-18-8-7-14-28(35(48)40-27)41-33(46)26-16-17-31-25(22-26)13-10-20-52-31/h4-6,11-12,16-17,22-23,27-30,32,45H,3,7-10,13-15,18-21H2,1-2H3,(H,39,49)(H,40,48)(H,41,46)(H,42,50)(H,43,47)/t23-,27+,28+,29-,30+,32+/m1/s1
InChIKeyAAOFWHOQKZYYHP-WPJUPHJLSA-N
XLogP0.89
TPSA195.27 Ų
H-Bond Donors6
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500718.85
LogP ≤ 50.89
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 108

Analyze N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide?
The IUPAC name of N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide (CID 135118702) is N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide.
What is the SMILES notation for N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide?
The canonical SMILES for N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide is CC[C@@H]1NC(=O)[C@@H](NC(=O)c2ccc3c(c2)CCCO3)CCCCNC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H]([C@@H](C)O)NC1=O.
What is the InChIKey of N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide?
The InChIKey is AAOFWHOQKZYYHP-WPJUPHJLSA-N. The full InChI is InChI=1S/C38H50N6O8/c1-3-27-34(47)43-32(23(2)45)37(50)42-29(21-24-11-5-4-6-12-24)38(51)44-19-9-15-30(44)36(49)39-18-8-7-14-28(35(48)40-27)41-33(46)26-16-17-31-25(22-26)13-10-20-52-31/h4-6,11-12,16-17,22-23,27-30,32,45H,3,7-10,13-15,18-21H2,1-2H3,(H,39,49)(H,40,48)(H,41,46)(H,42,50)(H,43,47)/t23-,27+,28+,29-,30+,32+/m1/s1.
What are the key properties of N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide?
N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide has a molecular weight of 718.85 g/mol, XLogP of 0.89, 6 rotatable bonds, 6 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6S,9S,12S,19S)-3-benzyl-9-ethyl-6-[(1R)-1-hydroxyethyl]-2,5,8,11,18-pentaoxo-1,4,7,10,17-pentazabicyclo[17.3.0]docosan-12-yl]-3,4-dihydro-2H-chromene-6-carboxamide is sourced from PubChem (CID 135118702), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).